Immunohistochemical analyses from the human protein atlas database confirmed RPA2 and POLI expression in prostate cancer tissue, while single-cell sequencing data from the tumor immune single-cell hub 2 database indicated differential expression across distinct cellular subpopulations. This evidence concerns the gene POLI and prostate carcinoma.